Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2 mouse model of glaucoma

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 3, 2006, Pages 986-996

  Inman, Denise M ^a   Sappington, Rebecca M ^b   Horner, Philip J ^a   Calkins, David J ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CORNEA; DBA 2 MOUSE; GLAUCOMA; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; MOUSE; NERVE FIBER; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; AGING; ANIMAL; CELL COUNT; CLOSED ANGLE GLAUCOMA; DBA MOUSE; DISEASE MODEL; GENOTYPE; OCULOPLETHYSMOGRAPHY; OPTIC DISK; OPTIC NERVE DISEASE; PATHOLOGY; RETINA GANGLION CELL;

AGING; ANIMALS; AXONS; CELL COUNT; CORNEA; DISEASE MODELS, ANIMAL; GENOTYPE; GLAUCOMA, ANGLE-CLOSURE; INTRAOCULAR PRESSURE; MICE; MICE, INBRED DBA; OPTIC DISK; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS; TONOMETRY, OCULAR;

EID: 33645420956     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0925     Document Type: Article

References (36)

1. Flanagan JG. Glaucoma update: epidemiology and new approaches to medical management. Ophthalmic Physiol Opt. 1998;18:126-132.
2. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714-720; discussion 829-730.
3. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41:741-748.
4. Brandt JD. The influence of corneal thickness on the diagnosis and management of glaucoma. J Glaucoma. 2001;10(suppl 1):S65-S67.
5. Copt RP, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol. 1999;117:14-16.
6. Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol. 2004;122:17-21.
7. Jonas JB, Stroux A, Velten I, Juenemann A, Martus P, Budde WM. Central corneal thickness correlated with glaucoma damage and rate of progression. Invest Ophthalmol Vis Sci. 2005;46:1269-1274.
8. Sihota R, Lakshmaiah NC, Titiyal JS, Dada T, Agarwal HC. Corneal endothelial status in the subtypes of primary angle closure glaucoma. Clin Exp Ophthalmol. 2003;31:492-495.
9. John SW, Smith RS, Savinova OV, et al. Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci. 1998;39:951-962.
10. Sheldon WG, Warbritton AR, Bucci TJ, Turturro A. Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab Anim Sci. 1995;45:508-518.
11. Schuettauf F, Rejdak R, Walski M, et al. Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol (Berl). 2004;107:352-358.
12. Danias J, Lee KC, Zamora MF, et al. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci. 2003;44:5151-5162.
13. Moore CG, Milne ST, Morrison JC. Noninvasive measurement of rat intraocular pressure with the Tono-Pen. Invest Ophthalmol Vis Sci. 1993;34:363-369.
14. Thanos S, Naskar R. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant. Exp Eye Res. 2004;79:119-129.
15. Reitsamer HA, Kiel JW, Harrison JM, Ransom NL, McKinnon SJ. Tonopen measurement of intraocular pressure in mice. Exp Eye Res. 2004;78:799-804.
16. Chang B, Smith RS, Hawes NL, et al. Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet. 1999;21:405-409.
17. Anderson MG, Smith RS, Hawes NL, et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet. 2002;30:81-85.
18. Sappington RM, Pearce DA, Calkins DJ. Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis. Invest Ophthalmol Vis Sci. 2003;44:3725-3731.
19. Calkins DJ, Sappington RM, Hendry SH. Morphological identification of ganglion cells expressing the alpha subunit of type II calmodulin-dependent protein kinase in the macaque retina. J Comp Neurol. 2005;481:194-209.
20. Pang IH, Wang WH, Cameron Millar J, Clark AF. Measurement of mouse intraocular pressure with the Tono-Pen. Exp Eye Res. 2005;81:359-360.
21. Avila MY, Carre DA, Stone RA, Civan MM. Reliable measurement of mouse intraocular pressure by a servo-null micropipette system. Invest Ophthalmol Vis Sci. 2001;42:1841-1846.
22. Danias J, Kontiola AI, Filippopoulos T, Mittag T. Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci. 2003;44:1138-1141.
23. Cohan BE, Bohr DF. Measurement of intraocular pressure in awake mice. Invest Ophthalmol Vis Sci. 2001;42:2560-2562.
24. Savinova OV, Sugiyama F, Martin JE, et al. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2001;2:12.
25. Jeon CJ, Strettoi E, Masland RH. The major cell populations of the mouse retina. J Neurosci. 1998;18:8936-8946.
26. Williams RW, Strom RC, Rice DS, Goldowitz D. Genetic and environmental control of variation in retinal ganglion cell number in mice. J Neurosci. 1996;16:7193-7205.
27. Mabuchi F, Aihara M, Mackey MR, Lindsey JD, Weinreb RN. Regional optic nerve damage in experimental mouse glaucoma. Invest Ophthalmol Vis Sci. 2004;45:4352-4358.
28. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci. 2003;8:s1140-1156.
29. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
30. Quigley HA, Green WR. The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology. 1979;86:1803-1830.
31. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99:635-649.
32. Anderson DR. What happens to the optic disc and retina in glaucoma? Ophthalmology. 1983;90:766-770.
33. Kim JW, Chen PP. Central corneal pachymetry and visual field progression in patients with open-angle glaucoma. Ophthalmology. 2004;111:2126-2132.
34. Iester M, Mermoud A. Retinal nerve fiber layer and physiological central corneal thickness. J Glaucoma. 2001;10:158-162.
35. Henderson PA, Medeiros FA, Zangwill LM, Weinreb RN. Relationship between central corneal thickness and retinal nerve fiber layer thickness in ocular hypertensive patients. Ophthalmology. 2005;112:251-256.
36. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47:977-985.